LAZARD ASSET MANAGEMENT LLC
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1207017
NEW YORK, NY
Position in RXRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,230,339
-$487,485 QoQ
Shares Held
400,762
-4.6% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LAZARD ASSET MANAGEMENT LLC holds $361,300,548 across 55 Biotechnology names. RXRX ranks #30 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
133,347 | $97,376,646 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
213,131 | $95,171,516 | |
| 3 | INCY |
Incyte Corp
|
219,881 | $20,695,199 | |
| 4 | ONC |
BeOne Medicines Ltd.
|
62,917 | $18,684,461 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
325,851 | $18,407,322 | |
| 6 | EXEL |
Exelixis, Inc.
|
372,600 | $15,980,814 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,004 | $13,137,970 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
42,723 | $8,076,783 |
All Filings in RXRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,230,339 | 400,762 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,717,824 | 420,006 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,416,400 | 495,164 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,046,081 | 404,364 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,677,470 | 506,138 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,757,546 | 555,850 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,232,809 | 642,308 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,931,185 | 524,158 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,798,259 | 280,668 | Shares | Sole | 2024-07-09 | |
| 2023-12-31 | $3,664,952 | 371,699 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,562,933 | 335,024 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,578,068 | 345,123 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,304,751 | 345,540 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,263,738 | 163,909 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $3,236,815 | 304,212 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,357,417 | 289,609 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,352,695 | 188,924 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,456,167 | 143,384 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||